• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌炎患儿扩张型心肌病进展的临床表现及早期预测因素

Clinical presentation and early predictors of progression to dilated cardiomyopathy in children with acute myocarditis.

作者信息

Luo Liu, Huang Yanyun, Qiao Xiaoyu, Pang Yusheng

机构信息

Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

出版信息

Front Pediatr. 2025 Jul 3;13:1616751. doi: 10.3389/fped.2025.1616751. eCollection 2025.

DOI:10.3389/fped.2025.1616751
PMID:40677288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12267237/
Abstract

OBJECTIVE

The aim of this study was to describe the characteristics and outcomes of acute myocarditis (AM) patients while seeking accessible and valid early predictors for the development of dilated cardiomyopathy (DCM).

METHODS

We conducted a retrospective evaluation of 136 consecutive AM patients admitted to our hospital. The patients were categorized into two groups according to their left ventricular ejection fraction (LVEF) at presentation: those with an impaired LVEF of ≤55% and those with a normal LVEF of >55%. Multivariate logistic regression analyses were conducted to identify early predictors of DCM.

RESULTS

The median age of the study participants was 10.35 years (5.60-14.70), and most of the participants (66.91%) were males. Thirty-eight (27.94%) patients had an LVEF of ≤55%. Compared with those with an LVEF >55%, patients with an LVEF ≤55% presented significantly elevated levels of cardiac troponin I (cTnI) and N-terminal pro-B-type natriuretic peptide (NT-proBNP), as well as more pronounced clinical manifestations, including a greater prevalence of fulminant myocarditis, New York Heart Association (NYHA) class II-IV, abnormal electrocardiogram results, and enlargement of the left ventricle on echocardiography. Univariate analysis revealed that patients with an LVEF of ≤55% had an increased risk of poor outcomes and DCM development. These patients faced the greatest likelihood of death and heart transplantation within the first year following discharge. During short-term follow-up, 15.44% of the children with AM progressed to DCM. According to the multivariable analysis, a higher baseline LV end-diastolic diameter z score (LVEDD z-score) independently predicted this progression (odds ratio [OR], 2.685; 95% confidence interval [CI], 1.232-5.851;  = 0.013).

CONCLUSIONS

Patients with AM and LVEF ≤55% had a more severe clinical course, higher rates of poor outcomes, and increased risk of DCM progression. Moreover, this subgroup was at the greatest risk for death and heart transplant within the first year post-discharge. During short-term follow-up, 15.44% of the children diagnosed with AM progressed to DCM, with a higher baseline LVEDD z-score identified as a potential early predictor for this progression.

摘要

目的

本研究旨在描述急性心肌炎(AM)患者的特征及预后,同时寻找可及且有效的扩张型心肌病(DCM)发生的早期预测指标。

方法

我们对我院收治的136例连续的AM患者进行了回顾性评估。根据患者就诊时的左心室射血分数(LVEF)将其分为两组:LVEF≤55%的受损组和LVEF>55%的正常组。进行多因素逻辑回归分析以确定DCM的早期预测指标。

结果

研究参与者的中位年龄为10.35岁(5.60 - 14.70),大多数参与者(66.91%)为男性。38例(27.94%)患者的LVEF≤55%。与LVEF>55%的患者相比,LVEF≤55%的患者心肌肌钙蛋白I(cTnI)和N末端B型脑钠肽原(NT-proBNP)水平显著升高,临床表现也更明显,包括暴发性心肌炎的患病率更高、纽约心脏协会(NYHA)心功能分级为II - IV级、心电图结果异常以及超声心动图显示左心室增大。单因素分析显示,LVEF≤55%的患者预后不良和发生DCM的风险增加。这些患者在出院后第一年内死亡和心脏移植的可能性最大。在短期随访中,15.44%的AM患儿进展为DCM。根据多变量分析,较高的基线左心室舒张末期直径z评分(LVEDD z评分)可独立预测这一进展(比值比[OR],2.685;95%置信区间[CI],1.232 - 5.851;P = 0.013)。

结论

AM且LVEF≤55%的患者临床病程更严重,预后不良率更高,DCM进展风险增加。此外,该亚组在出院后第一年内死亡和心脏移植的风险最大。在短期随访中,15.44%被诊断为AM的儿童进展为DCM,较高的基线LVEDD z评分被确定为这一进展的潜在早期预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/12267237/79ff39b670ba/fped-13-1616751-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/12267237/4d050196cff8/fped-13-1616751-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/12267237/79ff39b670ba/fped-13-1616751-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/12267237/4d050196cff8/fped-13-1616751-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/914d/12267237/79ff39b670ba/fped-13-1616751-g002.jpg

相似文献

1
Clinical presentation and early predictors of progression to dilated cardiomyopathy in children with acute myocarditis.急性心肌炎患儿扩张型心肌病进展的临床表现及早期预测因素
Front Pediatr. 2025 Jul 3;13:1616751. doi: 10.3389/fped.2025.1616751. eCollection 2025.
2
Intravenous immunoglobulin for presumed viral myocarditis in children and adults.静脉注射免疫球蛋白用于儿童和成人疑似病毒性心肌炎的治疗。
Cochrane Database Syst Rev. 2015 May 20(5):CD004370. doi: 10.1002/14651858.CD004370.pub3.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Prognosis of adults and children following a first unprovoked seizure.首次无诱因发作后成人和儿童的预后。
Cochrane Database Syst Rev. 2023 Jan 23;1(1):CD013847. doi: 10.1002/14651858.CD013847.pub2.
5
Cardiac Myosin Inhibition in Heart Failure With Normal and Supranormal Ejection Fraction: Primary Results of the EMBARK-HFpEF Trial.射血分数正常和超常的心力衰竭患者的心肌肌球蛋白抑制作用:EMBARK-HFpEF试验的主要结果
JAMA Cardiol. 2025 Feb 1;10(2):170-175. doi: 10.1001/jamacardio.2024.3810.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
10
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.

本文引用的文献

1
The diagnosis and treatment of pediatric clinical myocarditis in China: a multicenter retrospective study.中国小儿临床心肌炎的诊断与治疗:一项多中心回顾性研究
Eur J Pediatr. 2024 Mar;183(3):1233-1244. doi: 10.1007/s00431-023-05362-w. Epub 2023 Dec 13.
2
Diagnostic Approach for Suspected Acute Myocarditis: Considerations for Standardization and Broadening Clinical Spectrum.疑似急性心肌炎的诊断方法:考虑标准化和拓宽临床谱。
J Am Heart Assoc. 2023 Sep 5;12(17):e031454. doi: 10.1161/JAHA.123.031454. Epub 2023 Aug 17.
3
Diagnosis and Treatment of Acute Myocarditis: A Review.
急性心肌炎的诊断与治疗:综述
JAMA. 2023 Apr 4;329(13):1098-1113. doi: 10.1001/jama.2023.3371.
4
Features and Outcomes of Histologically Proven Myocarditis With Fulminant Presentation.组织学证实的暴发性心肌炎的特征和结局。
Circulation. 2022 Nov 8;146(19):1425-1433. doi: 10.1161/CIRCULATIONAHA.121.058869. Epub 2022 Sep 27.
5
Diagnosis, risk stratification and management of myocarditis.心肌炎的诊断、风险分层与管理
Heart. 2022 Aug 25;108(18):1486-1497. doi: 10.1136/heartjnl-2021-319027.
6
Could the unfortunate outcome of pediatric acute myocarditis be predicted? Factors contributing to a poor outcome in myocarditis.儿科急性心肌炎的不幸结局能否预测?影响心肌炎不良结局的因素。
Rev Port Cardiol (Engl Ed). 2021 Sep;40(9):631-638. doi: 10.1016/j.repce.2020.10.020.
7
Diagnosis and Management of Myocarditis in Children: A Scientific Statement From the American Heart Association.儿童心肌炎的诊断和治疗:美国心脏协会的科学声明。
Circulation. 2021 Aug 10;144(6):e123-e135. doi: 10.1161/CIR.0000000000001001. Epub 2021 Jul 7.
8
Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes.暴发性心肌炎:从病因到治疗和结局的全面综述。
Signal Transduct Target Ther. 2020 Dec 11;5(1):287. doi: 10.1038/s41392-020-00360-y.
9
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.急性心肌炎和慢性炎症性心肌病的管理:专家共识文件。
Circ Heart Fail. 2020 Nov;13(11):e007405. doi: 10.1161/CIRCHEARTFAILURE.120.007405. Epub 2020 Nov 12.
10
Epidemiology Characteristics and Outcome of Patients With Clinically Diagnosed Acute Myocarditis.临床诊断为急性心肌炎患者的流行病学特征和结局。
Am J Med. 2020 Apr;133(4):492-499. doi: 10.1016/j.amjmed.2019.10.015. Epub 2019 Nov 9.